title: Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen.
abstract: Choroidal neovascular membranes are a rare cause of decreased vision in children with optic nerve head drusen. We present a case of bilateral choroidal neovascular membranes associated with optic nerve head drusen in a 5-year-old boy who was successfully treated with a combination of focal laser photocoagulation and intravitreal bevacizumab.
authors.affiliation: Department of Ophthalmology, University of Florida College of Medicine, Gainesville, Florida 32610, USA. robknape@yahoo.com
authors.forename: Robert M
authors.initials: RM
authors.lastname: Knape
authors.forename: Eric M
authors.initials: EM
authors.lastname: Zavaleta
authors.forename: Charles L
authors.initials: CL
authors.lastname: Clark
authors.forename: Nausheen
authors.initials: N
authors.lastname: Khuddus
authors.forename: Marc C
authors.initials: MC
authors.lastname: Peden
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002675:Child, Preschool; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D003131:Combined Modality Therapy; D005451:Fluorescein Angiography; D007839:Functional Laterality; D006801:Humans; D058449:Intravitreal Injections; D017075:Laser Coagulation; D008297:Male; D009898:Optic Disk; D015594:Optic Disk Drusen / Q000150:complications* / Q000175:diagnosis; D019233:Retreatment; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab